- Home
- MDXG vs FORTY Comparison
MDXG vs FORTY Comparison
Compare MDXG & FORTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- FORTY
- Stock Information
- Founded
- MDXG 2006
- FORTY 1985
- Country
- MDXG United States
- FORTY Israel
- Employees
- MDXG N/A
- FORTY N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- FORTY EDP Services
- Sector
- MDXG Health Care
- FORTY Technology
- Exchange
- MDXG Nasdaq
- FORTY Nasdaq
- Market Cap
- MDXG 1.3B
- FORTY 1.4B
- IPO Year
- MDXG N/A
- FORTY 1997
- Fundamental
- Price
- MDXG $7.98
- FORTY $99.77
- Analyst Decision
- MDXG Strong Buy
- FORTY
- Analyst Count
- MDXG 5
- FORTY 0
- Target Price
- MDXG $12.00
- FORTY N/A
- AVG Volume (30 Days)
- MDXG 518.6K
- FORTY 1.0K
- Earning Date
- MDXG 02-26-2025
- FORTY 03-18-2025
- Dividend Yield
- MDXG N/A
- FORTY 1.26%
- EPS Growth
- MDXG N/A
- FORTY 18.72
- EPS
- MDXG 0.52
- FORTY 4.83
- Revenue
- MDXG $342,804,000.00
- FORTY $2,706,303,000.00
- Revenue This Year
- MDXG $9.56
- FORTY N/A
- Revenue Next Year
- MDXG $9.19
- FORTY N/A
- P/E Ratio
- MDXG $15.86
- FORTY $20.17
- Revenue Growth
- MDXG 10.93
- FORTY 2.60
- 52 Week Low
- MDXG $5.47
- FORTY $69.07
- 52 Week High
- MDXG $10.14
- FORTY $100.00
- Technical
- Relative Strength Index (RSI)
- MDXG 35.32
- FORTY 67.12
- Support Level
- MDXG $7.81
- FORTY $99.43
- Resistance Level
- MDXG $8.54
- FORTY $100.00
- Average True Range (ATR)
- MDXG 0.23
- FORTY 0.82
- MACD
- MDXG -0.05
- FORTY 0.47
- Stochastic Oscillator
- MDXG 18.09
- FORTY 97.70
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About FORTY Formula Systems (1985) Ltd.
Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources; Michpal; ZAP Group and Others. The majority of the company's revenue comes from Israel.